By
Drug Target Review2025-02-04T08:00:04
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides that can bind to and destroy previously untreatable proteins.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-06-24T13:00:00
Sponsored by HUB Organoids
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-07-04T10:05:58
Sponsored by Revvity
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud